Immunological pathways – no single molecular target

The term Immunological pathways – no single molecular target refers to a broad set of biological processes involving the immune system rather than a single, discrete molecular entity like a receptor or enzyme. These pathways encompass the complex interactions between various cells, such as T cells, B cells, and macrophages, and signaling molecules like cytokines and chemokines that coordinate the body's defense against pathogens and internal threats (Janeway's Immunobiology, 9th ed.). In a therapeutic context, drugs associated with this category often exert systemic effects to either suppress overactive immune responses in autoimmune diseases or stimulate the immune system to combat cancer or infections (StatPearls, Corticosteroids). Because this classification lacks a single molecular target, it typically includes treatments like broad-spectrum immunosuppressants, vaccines, or complex biologics that influence multiple nodes within the immune network (PubMed, PMID: 30215614). Understanding these pathways is crucial for managing inflammatory conditions, though the lack of specificity can lead to significant side effects such as general immunosuppression and increased susceptibility to opportunistic infections (NIH, Immune System and Disorders).

Other names

Immune system pathwaysImmunomodulatory pathwaysNon-specific immune modulationImmune response network

Broad modulation of immune cell signaling, gene transcription, and cytokine production across multiple cell types rather than binding to a single specific protein.